Premium
Large private equity investments in multi-specialty hospitals and sustained investor interest across the single-specialty space were the showstoppers in the Indian healthcare industry, besides a couple of merger deals.However, quality issues at some of the more prominent hospital chains and warnings issued by the US drug regulator to a few ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
